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a B S T r a c T
iNTrodUcTioN: recent studies showed a possible association between hyperaldosteronism and secondary hyperpara-
thyroidism leading to reduced bone health, however results are conflicting.
eVideNce acQUiSiTioN: We conducted a meta-analysis to evaluate the relationship between primary aldosteronism 
(Pa) with bone biochemical markers and to assess bone mineral density in patients with primary aldosteronism.
EVIDENCE SYNTHESIS: A total of 939 subjects were examined (37.5% with PA). Patients with PA had signifi-
cantly higher serum parathyroid hormone, lower serum calcium, higher urine calcium excretion and higher serum 
alkaline phosphatase compared to patients without PA, with no significant difference in serum vitamin D between 
both groups. Bone mineral density of lumbar spine, femoral neck and total neck of femur were similar between two 
groups. With PA treatment, there was a significant increment in serum calcium and reduction in serum parathyroid 
hormone.
coNclUSioNS: Pa is associated with hypercalciuria with subsequent secondary hyperparathyroidism. This potentially 
affects bone health. We recommend this to be part of complication screening among patients with Pa.
(Cite this article as: loh HH, Yee a, loh HS. Bone health among patients with primary aldosteronism: a systematic review 
and meta-analysis. Minerva endocrinol 2019;44:000–000. doi: 10.23736/S0391-1977.18.02867-5)
Key words: Bone density; calcium; Bone fractures; Hyperaldosteronism; osteoporosis; Secondary hyperparathyroid-
ism.
Minerva endocrinologica 2019 mese;44(0):000–000
doi: 10.23736/S0391-1977.18.02867-5
© 2018 ediZioNi MiNerVa Medica
online version at http://www.minervamedica.it
Introduction
Primary aldosteronism (Pa) is a disorder of the adrenal gland, causing autonomous pro-
duction of aldosterone. it is the most common 
cause of secondary hypertension among middle-
aged adults.1-3 it is well-known to have detrimen-
tal effects on cardiovascular and renal system.4 
osteoporosis leading to bone fractures impairs 
quality of life and is associated with increased 
morbidity and mortality.5-7
animal studies showed that rats which were 
given aldosterone and salt had a reduction in 
bone mineral density and cortical bone strength.8 
This led to a few recent studies which have iden-
tified the possible association between hyper-
aldosteronism and reduced bone health and in-
creased fracture risk.9-14
although the exact mechanism is unknown, 
reduced bone health in patients with hyperal-
dosteronism was believed to be due to hyper-
magnesuria and hypercalciuria leading to bone 
loss.15 recent studies also found an association 
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